Baxter International Inc. Q1 2026 Earnings Call Summary
Baxter International reported a 1% decline in first-quarter organic sales, attributed to challenging year-over-year comparisons and shipment issues with the Novum LVP infusion pump. The company is executing a three-pillar turnaround strategy focused on stabilizing operations, strengthening its balance sheet, and improving efficiency through new systems.
Tickers: $BAX
Topics: earnings guidance operational_performance turnaround_strategy